Spontaneous Coronary Artery Dissection (SCAD) with Dr. Sharonne Hayes Part 2

08/20/22 • 23 min

We would love to hear your thoughts on the episodes!

Dr Sharoanne Hayes and Dr. Thomas Nero continue their discussion of SCAD focusing on genetics, trial design and the role of online registries as well as the holistic treatment of the SCAD patient. This is part two of two.

We would love to hear your thoughts on the episodes!

Previous Episode

Evaluation of Coronary Inflammation with CT angiography and Fat Attenuation Indexing

We would love to hear your thoughts on the episodes!

Dr. Nero discusses evaluation of coronary artery disease and coronary inflammaiton with Dr. Cheerag Shirodaria from the University of Oxford. Dr. Shirodaria along with Prof. Charalambos Antonidies at Caristo Diagnostics have developed a ground breaking technology that allows us to evaluate not just the severity of a coronary artery lesion, but also how inflamed it is and how likely it is to cause fatal and non-fatal myocardial infarction. In addition, since it is a biologically active "marker" the Fat Attenuation Index (FAI) can also be used a a way to evaluate success of medical intervention. Using computer post processing from standard 64 or 128 slice CT coronary angiography, they have been able to evaluate not just the vulnerable patient but also (possibly) the vulnerable plaque.

Next Episode

Pragmatic Clinical Trials and EVOLVE-MI with Dr Christopher Cannon

We would love to hear your thoughts on the episodes!

Dr Christopher Cannon discusses the potential of Pragmatic Clinical Trials in our research armamentarium with Dr. Thomas Nero. They review the EVOLVE-MI trial for Early use of Evolocumab after Myocardial Infarction in detail and highlight the potential for future research.